ARCHIVES

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

This article is from The Cancer Letter archive.

Vol. 23 No. 15 | April 18, 1997

Download PDF Visit The Full Archive

Related Articles

IMRT Usage and Cost Related to Geography And Medicare Reimbursement Policy, Study Finds

April 29, 2011

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

Reagan Signs Appropriations Bill, Vetoes Biomedical Research Authorization Measure; Capitol Hill Angry

November 16, 1984

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

1981 Budget By Funding Mechanism

June 1, 1979

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

November 3, 1989